Literature DB >> 27175453

Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry.

David R Holmes, Rick A Nishimura, Frederick L Grover, Ralph G Brindis, John D Carroll, Fred H Edwards, Eric D Peterson, John S Rumsfeld, David M Shahian, Vinod H Thourani, E Murat Tuzcu, Sreekanth Vemulapalli, Kathleen Hewitt, Joan Michaels, Susan Fitzgerald, Michael J Mack.   

Abstract

BACKGROUND: The Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter Valve Therapy (TVT) Registry has been a joint initiative of the STS and the ACC in concert with multiple stakeholders. The TVT Registry has important information regarding patient selection, delivery of care, science, education, and research in the field of structural valvular heart disease.
OBJECTIVES: This report provides an overview on current U.S. TVT practice and trends. The emphasis is on demographics, in-hospital procedural characteristics, and outcomes of patients having transcatheter aortic valve replacement (TAVR) performed at 348 U.S. centers.
METHODS: The TVT Registry captured 26,414 TAVR procedures as of December 31, 2014. Temporal trends between 2012 and 2013 versus 2014 were compared.
RESULTS: Comparison of the 2 time periods reveals that TAVR patients remain elderly (mean age 82 years), with multiple comorbidities, reflected by a high mean STS predicted risk of mortality (STS PROM) for surgical valve replacement (8.34%), were highly symptomatic (New York Heart Association functional class III/IV in 82.5%), frail (slow 5-m walk test in 81.6%), and have poor self-reported health status (median baseline Kansas City Cardiomyopathy Questionnaire score of 39.1). Procedure performance is changing, with an increased use of moderate sedation (from 1.6% to 5.1%) and increase in femoral access using percutaneous techniques (66.8% in 2014). Vascular complication rates are decreasing (from 5.6% to 4.2%), whereas site-reported stroke rates remain stable at 2.2%.
CONCLUSIONS: The TVT Registry provides important information on characteristics and outcomes of TAVR in contemporary U.S. clinical practice. It can be used to identify trends in practice and opportunities for quality improvement.

Entities:  

Mesh:

Year:  2016        PMID: 27175453     DOI: 10.1016/j.athoracsur.2015.10.049

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  29 in total

Review 1.  Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When?

Authors:  Davide Cao; Mauro Chiarito; Paolo Pagnotta; Bernhard Reimers; Giulio G Stefanini
Journal:  Interv Cardiol       Date:  2018-05

2.  Understanding Neurologic Complications Following TAVR.

Authors:  Ghare Mohammed Imran; Lansky Alexandra
Journal:  Interv Cardiol       Date:  2018-01

Review 3.  The transition from transesophageal to transthoracic echocardiography during transcatheter aortic valve replacement: an evolving field.

Authors:  Menhel Kinno; Eric P Cantey; Vera H Rigolin
Journal:  J Echocardiogr       Date:  2018-11-21

4.  Peripheral Artery Disease and Transcatheter Aortic Valve Replacement Outcomes: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Therapy Registry.

Authors:  Alexander C Fanaroff; Pratik Manandhar; David R Holmes; David J Cohen; J Kevin Harrison; G Chad Hughes; Vinod H Thourani; Michael J Mack; Matthew W Sherwood; W Schuyler Jones; Sreekanth Vemulapalli
Journal:  Circ Cardiovasc Interv       Date:  2017-10       Impact factor: 6.546

5.  Rac1 mediates cadherin-11 induced cellular pathogenic processes in aortic valve calcification.

Authors:  Kiran A Vaidya; Matthew P Donnelly; Ablajan Mahmut; Jae Woong Jang; Terence W Gee; Marine-Ayan Ibrahim Aibo; Robert Bossong; Clare Hall; Sanjay Samb; Jonathan Chen; Jonathan T Butcher
Journal:  Cardiovasc Pathol       Date:  2022-01-21       Impact factor: 2.185

6.  Applicability of Transcatheter Aortic Valve Replacement Trials to Real-World Clinical Practice: Findings From EXTEND-CoreValve.

Authors:  Neel M Butala; Eric Secemsky; Dhruv S Kazi; Yang Song; Jordan B Strom; Kamil F Faridi; J Matthew Brennan; Sammy Elmariah; Changyu Shen; Robert W Yeh
Journal:  JACC Cardiovasc Interv       Date:  2021-10-11       Impact factor: 11.075

Review 7.  Role of Echocardiography in Transcatheter Valvular Heart Disease Interventions.

Authors:  Omar K Khalique; Rebecca T Hahn
Journal:  Curr Cardiol Rep       Date:  2017-10-27       Impact factor: 2.931

8.  Calcific Aortic Stenosis: New Approaches to an Old Disease.

Authors:  Jerry D Kennett; Benjamin Z Galper
Journal:  Mo Med       Date:  2016 Sep-Oct

9.  Transcatheter aortic valve implantation operators - get involved in imaging!

Authors:  Miriam Brinkert; Stefan Toggweiler
Journal:  World J Cardiol       Date:  2017-12-26

Review 10.  Coronary Assessment and Revascularization Before Transcutaneous Aortic Valve Implantation: An Update on Current Knowledge.

Authors:  Muhammad Sabbah; Thomas Engstrøm; Ole De Backer; Lars Søndergaard; Jacob Lønborg
Journal:  Front Cardiovasc Med       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.